Based on previous studies done in mice, researchers observed that GLP-1 agonists/DPP-4 inhibitors work to reduce inflammation in the gut, so they proposed that the same mechanism may occur in humans (5, 6)
Eps Ind A is significantly saturated in the WISE W1, W2 and W3 observations (the WISE source catalogue 60 lists saturation fractions of w1sat = 0.253, w2sat = 0.239 and w3sat = 0.144)
Medication delivered If eligible, medication ships directly to patients door
Berberine attenuates the abnormal ectopic lipid deposition in skeletal muscle
Yes, its mechanism of inhibiting NNMT can contribute to increased fat metabolism and decreased fat storage, supporting weight loss efforts
The trade-off is that side effects may peak during fasting hours the next day, though for most people on a stable dose this isnt a big issue